(Q24247189)

2

0 references

Zhao Hui Sha

3

0 references

Youping Li

4

0 references

I Cao

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 April 2004

0 references

published in

0 references

cites work

Acyclovir prophylaxis of varicella in children with renal disease receiving steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Intravenous immune globulins: an update for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Prevention of serious bacterial infection in children with nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Nephrotic syndrome: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Microbiological spectrum of septicemia and peritonitis in nephrotic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Toxicity of complementary therapies: an eastern perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Urinary tract infection in nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Pediatric nosocomial infections: children are not little adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Immunization practices in childhood nephrotic syndrome: a survey of North American pediatric nephrologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2

Risk factors for steroid dependency in children with idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003964.PUB2